Todd Anderson alias Dr. Dispensary Profit

Todd Anderson is not licensed or approved by Minnesota Board of Chiropractic Examiners to advertise You can stay on track with refill reminders timed and personalized to recommended dosages. as within their scope of practice.

You can stay on track with refill reminders timed and personalized to recommended dosages.

Supports

High-quality evidence shows that electronic and IT-based reminders (including SMS, phone calls, devices, and mobile apps) can modestly improve medication adherence and refill behavior in some chronic conditions, which indirectly supports the idea that refill reminders can help people stay on track.^{[3][6][8][11][9][15]} Randomized trials in type 2 diabetes and other chronic diseases report higher refill adherence when patients receive real-time monitoring plus SMS reminders or pharmacist late‑to‑refill reminder calls compared with usual care.^[7][8][14] Systematic reviews and meta-analyses of electronic or IT-based reminder interventions find small-to-moderate improvements in adherence (pooled effect sizes around Cohen’s d 0.3–0.4), indicating that reminder-based strategies are a plausible, evidence-based component of adherence support.^{[3][5][11][4][9][15]}

Contradicts

The influencer’s claim is broad and implies that reminder timing and personalization to recommended dosages are reliably sufficient to keep patients “on track,” which is not supported by the evidence. Several randomized trials show no clinically meaningful or sustained improvement in refill adherence from electronic reminder devices alone, even when combined with counseling, for lipid-lowering therapy and other statins.^[10][18] Large pragmatic trials of text-message behavioral nudges targeting late refills for cardiovascular medications report no significant improvement in 12‑month pharmacy refill adherence or clinical outcomes compared with usual care after appropriate statistical correction, suggesting that simple timed or behaviorally tailored messages have limited impact in real-world populations.^[12][13][16] Meta-analyses and systematic reviews emphasize that reminder effects are generally small, short-term, and highly context-dependent, and that adherence is influenced by many factors beyond reminders (beliefs about medications, side effects, cost, complexity of regimen, health literacy, and social support), so reminders alone are an incomplete solution.^{[3][5][11][4][9][15]} Major guidelines in areas like hypertension management and clinical nutrition focus on individualized dosing and regimen design but do not endorse refill reminders, by themselves, as a primary or sufficient adherence strategy.^{[0][1][2][3][4]}

Mainstream view

The mainstream medical view is that electronic or IT-based refill reminders (via SMS, phone calls, devices, or apps) can produce small to moderate improvements in medication adherence for some patients and conditions, but they are not reliably sufficient on their own to keep most patients on track with complex chronic therapies.^{[3][11][9][15]} Evidence-based care emphasizes comprehensive adherence support: clear patient education, simplification of regimens, addressing side effects and costs, motivational and behavioral interventions, and regular follow-up, with reminder systems as one optional adjunct rather than a stand‑alone solution.^{[0][1][2][5][11]} Dosing recommendations are individualized according to disease-specific guidelines (e.g., hypertension, nutrition in chronic disease), and while technology can personalize reminder timing to these regimens, this personalization is not yet established as a robust determinant of adherence or clinical outcomes in high‑quality trials.^{[0][1][2][16]} Overall, mainstream practice treats refill and dose reminders as helpful tools within multifaceted adherence programs, not as guarantees that patients will stay on track.

In their own wordsView sourceArchived copy

“You can stay on track with refill reminders timed and personalized to recommended dosages.”

Rule: Minn. Stat. § 148.01, subd. 1(1)-(2)